Trial Profile
The Role of Orexin in Human Panic Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2021
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Panic disorder
- Focus Pharmacokinetics
- 04 Jun 2021 Status changed from active, no longer recruiting to completed.
- 09 Aug 2019 Planned End Date changed from 1 Dec 2019 to 1 Aug 2020.
- 09 Aug 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Aug 2020.